Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia

NCT04830943 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
250
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Assiut University